SHAREHOLDERS' EQUITY

12 Months Ended

Dec. 31, 2024

Stockholders' Equity Attributable to Parent [Abstract]

SHAREHOLDERS' EQUITY

NOTE 12:- SHAREHOLDERS' EQUITY

Share Option Plan:

The Company’s 2018 Share Incentive Plan (the "Plan") authorizes the grant of options to purchase shares and restricted shares units (“RSUs”) to officers, employees, directors and consultants of the Company and its subsidiaries. Awards granted under the Plan to participants in various jurisdictions may be subject to specific terms and conditions for such grants as may be approved by the Company’s board from time to time.

Each option granted under the Plan is exercisable for a period of ten years from the date of the grant of the option or the expiration dates of the option plan. The options primarily vest gradually over four years of employment.

During 2022, 28,000 options were granted under the Plan and 9,321 options were exercised. During 2023, 151,000 options were granted under the Plan and 171,015 options were exercised. During 2024, 87,000 options were granted under the Plan and 68,347 options were exercised. The total fair value of the options granted is being recognized over a four-year vesting period.

As of December 31, 2024, options to purchase 369,809 ordinary shares were outstanding under the Plan, exercisable at an average exercise price of $8.30 per share. The share-based compensation expense related to employees' equity-based awards, recognized during 2024, 2023 and 2022 was $607, $363 and $250, respectively.

A summary of employee option activity under the Plan as of December 31, 2024 and changes during the year ended December 31, 2024 are as follows:

	Number of options		Weighted-average exercise price		Weighted- average remaining contractual life (in years)		Aggregate intrinsic value (in thousands)
Outstanding at January 1, 2024		375,156		6.49		8.1		2,799
Granted		87,000		14.13		9.4		-
Exercised		68,347		5.00		4.9		-
Forfeited		24,000		10.08		8.8		-
Outstanding at December 31, 2024		369,809		8.30		7.8		992
Exercisable at December 31, 2024		163,557		6.03		6.7		822

The weighted-average fair value of options granted during the years ended December 31, 2024, 2023 and 2022 were $9.20, $5.90 and $2.67, respectively. The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company's closing share price on the last trading day of the fourth quarter of fiscal 2024 and 2023 and the exercise price, multiplied by the number of in-the-money options). This amount changes based on the fair market value of the Company's share. As of December 31, 2024, there was approximately $1,272 of unrecognized compensation costs related to non-vested share-based compensation arrangements granted under the Company's share option plans. This cost is expected to be recognized over a period of up to 4 years. The total intrinsic value of options exercised during the years ended December 31, 2024 and 2023 was $0.88 million and $1.14 million, respectively.